Proper Medical Writingsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-03-04
Share capital
10 000,00 PLN
Activity description

Proper Medical Writing is a company that specializes in creating scientific medical texts and clinical research documentation, including clinical study protocols and safety assessment reports. They provide professional support for researchers in preparing high-quality publications and offer comprehensive assistance to medical device manufacturers, including certification advice and quality management system implementation. Additionally, they conduct training workshops for healthcare professionals and researchers on data presentation techniques.

Registered address
ul. Panieńska 9/12, 03-704 Warszawa, Poland
Website
Email
Email address current
Phone
Social media

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2026.

Results vs industry

Revenue
This companyUSD 514.85kMedianUSD 38.31kAverageUSD 2.31m
Net profit
This companyUSD 36.61kMedianUSD -1.50kAverageUSD -84.98k
Operating costs
This companyUSD 446.55kMedianUSD 56.25kAverageUSD 2.29m
Assets
This companyUSD 138.44kMedianUSD 116.77kAverageUSD 2.72m

Bank accounts

Registered as a VAT taxpayer on 2014-04-09. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

7 public aid cases recorded, with a total value of $18,798.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
—
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
—
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
—

Tenders

No recorded participation in tenders.

Authorized Representatives

Agnieszka Linkiewicz Zegan — Attorney-in-fact (sole)
Maciej Grzegorz Bagiński — Management Board Member
Maria Kołtowska Häggström — Management Board Member
Dorota Jolanta Szymańska — Attorney-in-fact (sole)

Manner of representation

Each member of the management board independently.

Ownership

OwnerSharesShare valueStake
Maciej Grzegorz Bagiński (58)
25$675.3125%
Maria Barbara Kołtowska Häggström (69)
25$675.3125%
Łukasz Nikodem Kołtowski (44)
25$675.3125%
Julia Anna Kosela (44)
25$675.3125%

Beneficial owners

Person
Maciej Grzegorz Bagiński (58)
Maria Barbara Kołtowska-Haggstrom (69)

Competitors

Name
SkinlabP.S.A.
Aurevia Polandsp. z o.o.
DigitmedS.A.
Medicofarma BiotechS.A.
SKIN Lab Internationalsp. z o.o.
CCTSsp. z o.o.
Createcsp. z o.o.
TCIsp. z o.o.
Dicellasp. z o.o.
Pharmaxi Polandsp. z o.o.

Change history

DateEvent
2020-12-22Address change
2016-03-21Address change
2015-09-21PKD change
2014-03-04Entered in the register

FAQ

Last updated: 2026-08-28